Spectinomycin Market Outlook 2035; Teva, Merck, Pfizer Shape Industry
The global spectinomycin market is evolving as a specialized antibiotic segment, supported by rising awareness of bacterial infections and the need for alternative treatment options in cases of antibiotic resistance or allergies. Unlike broad-spectrum antibiotics, spectinomycin occupies a targeted therapeutic niche, particularly in treating specific infections such as gonorrhea...
0 Comments 0 Shares 5 Views